Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variantsRonan P. Kelly, David S. Small, Joseph A. Jakubowski et al.|British Journal of Clinical Pharmacology|2011Cited by 50
Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy chinese and white volunteers: An open-label trialDavid S. Small, Ronan P. Kelly, Christopher D. Payne et al.|Clinical Therapeutics|2010Cited by 47
AS-248: Prasugrel and Clopidogrel in Chinese CYP2C19 Allelic Variants following Maintenance DosesSandra C. Kirkwood, Ronan P. Kelly, Joseph A. Jakubowski et al.|The American Journal of Cardiology|2009Cited by 2